Altrius Capital Management Inc Boosts Stock Position in LyondellBasell Industries (NYSE:LYB)

Altrius Capital Management Inc grew its holdings in shares of LyondellBasell Industries (NYSE:LYBFree Report) by 16.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 97,953 shares of the specialty chemicals company’s stock after buying an additional 14,117 shares during the period. LyondellBasell Industries accounts for about 2.0% of Altrius Capital Management Inc’s holdings, making the stock its 14th largest holding. Altrius Capital Management Inc’s holdings in LyondellBasell Industries were worth $7,275,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Hosking Partners LLP lifted its stake in LyondellBasell Industries by 59.2% during the fourth quarter. Hosking Partners LLP now owns 405,028 shares of the specialty chemicals company’s stock worth $30,081,000 after purchasing an additional 150,592 shares during the last quarter. VELA Investment Management LLC lifted its position in shares of LyondellBasell Industries by 38.4% during the 4th quarter. VELA Investment Management LLC now owns 6,697 shares of the specialty chemicals company’s stock worth $497,000 after buying an additional 1,858 shares during the last quarter. Fort Sheridan Advisors LLC boosted its holdings in shares of LyondellBasell Industries by 8.6% in the 4th quarter. Fort Sheridan Advisors LLC now owns 18,392 shares of the specialty chemicals company’s stock valued at $1,366,000 after buying an additional 1,457 shares in the last quarter. Generali Investments Towarzystwo Funduszy Inwestycyjnych grew its position in shares of LyondellBasell Industries by 26.3% in the 4th quarter. Generali Investments Towarzystwo Funduszy Inwestycyjnych now owns 1,200 shares of the specialty chemicals company’s stock valued at $89,000 after buying an additional 250 shares during the last quarter. Finally, Versor Investments LP raised its stake in LyondellBasell Industries by 168.7% during the 4th quarter. Versor Investments LP now owns 33,586 shares of the specialty chemicals company’s stock worth $2,494,000 after acquiring an additional 21,086 shares in the last quarter. 71.20% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Robin W.T. Buchanan acquired 5,000 shares of LyondellBasell Industries stock in a transaction that occurred on Friday, December 13th. The stock was purchased at an average price of $76.06 per share, for a total transaction of $380,300.00. Following the completion of the purchase, the director now directly owns 18,175 shares of the company’s stock, valued at approximately $1,382,390.50. This trade represents a 37.95 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.11% of the company’s stock.

LyondellBasell Industries Trading Down 0.3 %

NYSE LYB opened at $76.01 on Friday. LyondellBasell Industries has a 52-week low of $72.21 and a 52-week high of $107.02. The firm has a 50-day moving average price of $75.86 and a 200 day moving average price of $84.66. The stock has a market capitalization of $24.68 billion, a P/E ratio of 18.36, a P/E/G ratio of 0.97 and a beta of 1.05. The company has a quick ratio of 1.13, a current ratio of 1.83 and a debt-to-equity ratio of 0.84.

LyondellBasell Industries (NYSE:LYBGet Free Report) last posted its quarterly earnings results on Friday, January 31st. The specialty chemicals company reported $0.75 EPS for the quarter, missing the consensus estimate of $1.28 by ($0.53). LyondellBasell Industries had a net margin of 3.39% and a return on equity of 15.97%. During the same period last year, the firm earned $1.26 earnings per share. Equities research analysts expect that LyondellBasell Industries will post 6.31 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on LYB shares. The Goldman Sachs Group dropped their price objective on LyondellBasell Industries from $96.00 to $86.00 and set a “sell” rating on the stock in a report on Thursday, December 12th. Wells Fargo & Company cut their price target on LyondellBasell Industries from $95.00 to $90.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. StockNews.com cut LyondellBasell Industries from a “buy” rating to a “hold” rating in a research note on Wednesday, January 8th. UBS Group lowered their target price on shares of LyondellBasell Industries from $77.00 to $76.00 and set a “neutral” rating on the stock in a research report on Monday, February 3rd. Finally, Mizuho reduced their price target on shares of LyondellBasell Industries from $97.00 to $85.00 and set a “neutral” rating for the company in a research report on Monday, December 9th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, LyondellBasell Industries currently has a consensus rating of “Hold” and a consensus price target of $88.25.

Get Our Latest Analysis on LyondellBasell Industries

About LyondellBasell Industries

(Free Report)

LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, Mexico, Italy, Poland, France, Japan, China, the Netherlands, and internationally. The company operates in six segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; Refining; and Technology.

Further Reading

Institutional Ownership by Quarter for LyondellBasell Industries (NYSE:LYB)

Receive News & Ratings for LyondellBasell Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LyondellBasell Industries and related companies with MarketBeat.com's FREE daily email newsletter.